Summary: Increasingly, people are telling us that their medications are no longer covered by their insurance policy, or are covered but with a much higher out-of-pocket price. Andy Pollack wrote a remarkable piece in The New York Times this week pulling back the curtain on the price of prescriptions, and what you can do about it. Hint: coupons and manufacturers’ cards are less and less valuable. Click here to read more….



Every Andy Pollack piece is a must-read, but this one is especially interesting.

“In dealing with health plans, drug companies are facing a new imperative — bargain or be banned,” he wrote.

“Determined to slow the rapid rise in drug prices, more health plans are refusing to cover certain drugs unless the companies charge less for them.

“The strategy appears to be getting pharmaceutical makers to compete on price. Some big-selling products, like the respiratory medicine Advair and the diabetes drug Victoza, have suffered precipitous declines in market share because Express Scripts, the biggest pharmacy benefits manager, recently stopped paying for them for many patients.

“ ‘There’s clearly more price competition in the marketplace,’ Andrew Witty, chief executive of GlaxoSmithKline, said, talking about Advair in a recent company earnings call.”

via Health Insurers Pressing Down on Drug Prices –

Jeanne Pinder

Jeanne Pinder  is the founder and CEO of ClearHealthCosts. She worked at The New York Times for almost 25 years as a reporter, editor and human resources executive, then volunteered for a buyout and founded...